Mutual of America Capital Management LLC decreased its position in shares of Amedisys, Inc. (NASDAQ:AMED – Free Report) by ...

Hospice Services Market Share Hospice Services Market is estimated to be valued at USD 4.81 Bn in 2025 and is expected to reach USD 8.97 Bn ...

Amedisys, for the fourth quarter of 2024, delivers year-over-year top-line growth across three of its segments - Home Health, ...

Handelsbanken Fonder AB boosted its position in shares of Amedisys, Inc. (NASDAQ:AMED – Free Report) by 25.6% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund ...

Hospice care, or end-of-life care, is a type of medical care for people in the final stages of a terminal illness. Rather than focusing on battling illness, hospice care is designed to ensure a ...

Amedisys Inc. (Nasdaq: AMED) experienced growth in home health during the fourth quarter of 2024, despite incurring merger-related costs from its pending ...

William Blair analyst Matt Larew maintained a Hold rating on Amedisys (AMED – Research Report) today. The company’s shares closed yesterday at $91.57. See what stocks are receiving Strong Buy ...

While the top- and bottom-line numbers for Amedisys (AMED) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics ...

Amedisys, Inc. (the "Company”) is a leading healthcare services company, delivering personalized home health, hospice and high acuity care services in the home. Amedisys is focused on delivering the ...

(2) Adjusted EBITDA is defined as net (loss) income attributable to Amedisys, Inc. before net interest expense, provision for income taxes and depreciation and amortization, excluding certain ...

Amedisys (AMED) delivered earnings and revenue surprises of -8.57% and 0.02%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?